Core Scientific Shares Slip as Q1 Loss Overshadows Revenue
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
Identifying the cheapest index funds for IRAs involves weighing costs against expected returns and risk. Learn practical benchmarking steps here.
22,746 articlesCore Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
Jumia's Q1 2026 earnings call offers a clear view of how the company plans to scale across Africa. This article break...
Owlet's Q1 2026 earnings provide a window into revenue drivers, margins, and strategic pivots. This guide breaks down...
As 2026 unfolds, a mix of rate shifts, debt pressures, and geopolitical strains create a tricky path for investors. T...
As AI models scale, the memory layer becomes the bottleneck that can shape profits. This piece explains why sandisk (...
A family estate in a hot real estate market yields a six-figure tax surprise when an inherited home’s stepped-up basi...
From boxed software on shelves to cloud-based subscriptions, software pricing has evolved dramatically. This guide br...
A stunning earnings moment has sparked questions about AMD's role in AI infrastructure. This deep-dive breaks down wh...
Get a clear read on Deft's Q1 2026 results, margins, and guidance. This analysis shows what the deft 2026 earnings tr...
Figma’s latest revenue surge has caught the eye of investors staring at a beaten-down stock. This article breaks down...
X-Energy lands ratings from six major firms, with five Buy or Overweight calls and a top target of $57, as investors ...
Deutsche Bank upgrades Humana to Buy with a near-doubling price target, as analysts anticipate a 2026 rebound in Medi...